Tiffany R. Farchione, MD

Efficacy trials in schizophrenia patients conducted from 1991 to 2009 showed an increasing rate of placebo response and a decline in treatment effect over time. This study explores these...

The recent FDA approval of aripiprazole tablets with sensor met with a myriad of reactions, including concerns about patient privacy and autonomy. In this Perspectives article, authors from the...